Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
cGAS-STING pathway expression as a prognostic tool in NSCLC.
Transl Lung Cancer Res. 2021 Jan;10(1):340-354. doi: 10.21037/tlcr-20-524.
Transl Lung Cancer Res. 2021.
PMID: 33569317
Free PMC article.
Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC.
Gammelgaard KR, Vad-Nielsen J, Clement MS, Weiss S, Daugaard TF, Dagnæs-Hansen F, Meldgaard P, Sorensen BS, Nielsen AL.
Gammelgaard KR, et al.
Transl Oncol. 2019 Mar;12(3):432-440. doi: 10.1016/j.tranon.2018.11.017. Epub 2018 Dec 16.
Transl Oncol. 2019.
PMID: 30562682
Free PMC article.
Item in Clipboard
Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells.
Vad-Nielsen J, Gammelgaard KR, Daugaard TF, Nielsen AL.
Vad-Nielsen J, et al. Among authors: gammelgaard kr.
Lung Cancer. 2019 Jun;132:132-140. doi: 10.1016/j.lungcan.2019.04.023. Epub 2019 Apr 18.
Lung Cancer. 2019.
PMID: 31097086
Item in Clipboard
Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors.
Pedersen JG, Madsen AT, Gammelgaard KR, Aggerholm-Pedersen N, Sørensen BS, Øllegaard TH, Jakobsen MR.
Pedersen JG, et al. Among authors: gammelgaard kr.
Cancers (Basel). 2020 May 30;12(6):1414. doi: 10.3390/cancers12061414.
Cancers (Basel). 2020.
PMID: 32486146
Free PMC article.
Item in Clipboard
Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells.
Clement MS, Gammelgaard KR, Nielsen AL, Sorensen BS.
Clement MS, et al. Among authors: gammelgaard kr.
Transl Lung Cancer Res. 2020 Oct;9(5):1904-1914. doi: 10.21037/tlcr-20-522.
Transl Lung Cancer Res. 2020.
PMID: 33209611
Free PMC article.
Item in Clipboard
Cite
Cite